SANGAMO THERAPEUTICS, INC. (SGMOQ) Operating income 2016–2025
SANGAMO THERAPEUTICS, INC. (SGMOQ) annual operating income history from SEC filings — each fiscal year as reported.
-$121.2MFY2025 · since FY2016: -$72.6M → -$121.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$121.2M | -16.6% |
| FY2024 | -$104.0M | +62.1% |
| FY2023 | -$274.0M | -36.1% |
| FY2022 | -$201.3M | -9.8% |
| FY2021 | -$183.3M | -41.5% |
| FY2020 | -$129.6M | -23.2% |
| FY2019 | -$105.2M | -36.3% |
| FY2018 | -$77.2M | -36.9% |
| FY2017 | -$56.4M | +22.3% |
| FY2016 | -$72.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice